Evaluating osteopontin as a biomarker of obesity related complications before and after metabolic and bariatric surgery: A systematic review and meta-analysis

被引：0
作者：
Ardizzone, Alessio [1 ]
Siracusa, Rosalba [1 ]
Capra, Anna Paola [1 ]
Di Paola, Rosanna [2 ]
Esposito, Emanuela [1 ]
Cuzzocrea, Salvatore [1 ,3 ]
D'Amico, Ramona [1 ]
Impellizzeri, Daniela [1 ]
机构：
[1] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno Alcontres 31, I-98166 Messina, Italy
[2] Univ Messina, Dept Vet Sci, I-98168 Messina, Italy
[3] Link Campus Univ, Via Casale San Pio 5 44, Rome, Italy
来源：
OBESITY RESEARCH & CLINICAL PRACTICE | 2025年 / 19卷 / 01期
关键词：
Osteopontin; Inflammatory biomarkers; Obesity; Metabolic and bariatric surgery; Meta-analysis; ADIPOSE-TISSUE; SLEEVE GASTRECTOMY; GASTRIC BYPASS; INFLAMMATION; EXPRESSION; INCREASES; CANCER;
D O I：
10.1016/j.orcp.2025.01.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background/Objectives: Obesity is a major public health concern, significantly elevating the risk of developing comorbid conditions such as type 2 diabetes mellitus and cardio-vascular diseases, while also shortening life expectancy. Currently, metabolic and bariatric surgery (MBS) is one of the most effective long-term interventions for achieving substantial weight loss, alongside notable improvements in overall quality of life. However, evidence suggests that these procedures may negatively affect bone health, leading to an increased risk of fractures. This systematic review and meta-analysis aim to assess the role of Osteopontin (OPN) as a potential biomarker for predicting both persistent inflammation and bone deterioration following MBS. Methods: A comprehensive search of scientific databases including PubMed (MEDLINE), Embase (OVID), and Web of Science, covering literature up to January 31, 2024, identified 6 studies that met the inclusion criteria for the systematic review. For the meta-analysis, data from 5 studies measuring circulating OPN levels pre- and post-surgery were pooled. Results: The combined analysis revealed a significant increase in OPN levels after MBS compared to baseline (OR: 24.56; 95 % CI: 13.30-35.81; p < 0.0001). Conclusions: These findings suggest that OPN may serve as a valuable biomarker for monitoring inflammation and assessing the risk of bone-related complications in patients following MBS.
引用
收藏
页码：19 / 27
页数：9
相关论文
共 54 条
  • [1] Lin X., Li H., Obesity: epidemiology, pathophysiology, and therapeutics, Front Endocrinol, 12, (2021)
  • [2] pp. 1-253, (2000)
  • [3] Apperley L.J., Blackburn J., Erlandson-Parry K., Gait L., Laing P., Senniappan S., Childhood obesity: a review of current and future management options, Clin Endocrinol, 96, 3, pp. 288-301, (2022)
  • [4] Ruze R., Liu T., Zou X., Song J., Chen Y., Xu R., Et al., Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments, Front Endocrinol, 14, (2023)
  • [5] Valenzuela P.L., Carrera-Bastos P., Castillo-Garcia A., Lieberman D.E., Santos-Lozano A., Lucia A., Obesity and the risk of cardiometabolic diseases, Nat Rev Cardiol, 20, 7, pp. 475-494, (2023)
  • [6] Rosa-Goncalves P., Majerowicz D., Pharmacotherapy of obesity: limits and perspectives, Am J Cardiovasc Drugs, 19, 4, pp. 349-364, (2019)
  • [7] Sandoval D.A., Patti M.E., Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia, Nat Rev Endocrinol, 19, 3, pp. 164-176, (2023)
  • [8] Athanasiadis D.I., Monfared S., Choi J.N., Selzer D., Banerjee A., Stefanidis D., Vertical banded gastroplasty revision to gastric bypass leads to effective weight loss and comorbidity and dysphagia symptom resolution, Obes Surg, 30, 9, pp. 3453-3458, (2020)
  • [9] Franco J.V., Ruiz P.A., Palermo M., Gagner M., A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding, Obes Surg, 21, 9, pp. 1458-1468, (2011)
  • [10] Khalid S.I., Omotosho P.A., Spagnoli A., Torquati A., Association of bariatric surgery with risk of fracture in patients with severe obesity, JAMA Netw Open, 3, 6, (2020)
123456